International Federation of Placenta Associations
International Federation of Placenta Associations
批准号:
10089460
负责人:
HELEN N JONES
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-01-27 至 2025-12-31
关键词:
AddressApoptosisAreaArgentinaAtmosphereAwardAwards and PrizesBarker HypothesisCanadaCancer BiologyChildClinicalCollaborationsCommunitiesDevelopmentDiabetes MellitusDisciplineDoctor of MedicineDoctor of PhilosophyEducational workshopEndocrinologyEnsureEuropeExposure toFemaleFetal GrowthFetal Growth RetardationFundingGenomicsGrantGrowth and Development functionHourHumanImmunologyIndividualInternationalInvestigationJapanKnowledgeLearningMetabolismMinorityMothersNatureNetherlandsNew ZealandNutrientObesityOralPathologyPhysiologicalPlacentaPlacental BiologyPre-EclampsiaPregnancyPregnancy lossRegulationReportingResearchResearch PersonnelRestRoleScheduleScientistSecureStructureStudentsTalentsTechnologyTimeTrainingTravelUnited States National Institutes of HealthUrsidae FamilyWomanWorkangiogenesisbasecareercareer developmentcostepigenomicshormonal signalslecturerlecturesmeetingsmultidisciplinarypleiotropismpostersprematureprogramsresearch and developmentsymposium
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This application seeks renewal of funding to cover travel costs to allow the attendance of 8-12
trainees and new investigators from the USA at the annual International Federation of Placenta
Associations (IFPA) meetings together with funding to support the travel costs of a senior US-
based investigator to these meetings where he/she will present an invited plenary lecture and
take part in workshop sessions. The many physiologic roles fulfilled by the human placenta in
support of fetal growth and development means that placental research is truly multidisciplinary
and meetings of the placental research community bring together clinicians, translational and
basic scientists of various specializations. Often these are individuals whose primary focus is
not the placenta but who recognize that their talents can be brought to bear on investigations in
this most multifaceted area. The highly successful annual IFPA meeting has served to bring
together clinicians and scientists, established senior, mid-career and junior investigators from
around the world, to report and discuss their findings in an atmosphere conducive to frank yet
amicable exchange. Meetings are scheduled in September/October of each year in Buenos
Aires, Argentina (2019), Amsterdam, The Netherlands (2020), Rotarua, New Zealand (2021),
Montreal, Canada (2022), Europe (2023) and Japan (2024). The meeting duration is 3 - 3 1/2
days with up to eight plenary sessions addressing specific aspects of placental function. The
main speaker in each plenary gives a state of the art presentation and is not necessarily a
placental biologist. Plenary sessions are accompanied by a corresponding interactive 2-hour
workshop session addressing controversial questions. At least two 3-hour poster discussion
sessions are scheduled and posters are displayed for the entire meeting to allow time for in
depth discussion of work particularly of new investigators. Oral sessions for new investigators
and trainees are scheduled with the best abstracts selected for these by the program
committee. Prizes are awarded for the best oral presentation and best poster presentations by
trainees or new investigators. Trainees and new investigators will be selected based on
competitive review of submitted first author abstracts for award of travel funds. The US–based
senior investigator will be selected by the meeting organizer and PI of this proposal.
There is always a high proportion (up to 60%) of women attendees, speakers and session
chairs at IFPA meetings ensuring adequate representation. In the last 14 years a previous
conference grant (PI: Myatt) has supported 121 young investigators of whom 89 were female
and 37 minorities. A significant majority are still engaged in the field.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Efficacy and safety of nanoparticle mediated placental gene therapy in nonhuman primates
-
批准号:10752759
-
项目类别:
-
资助金额:$67.64万
-
财政年份:2023
-
负责人:HELEN N JONES
-
依托单位:
International Federation of Placenta Associations
-
批准号:10321240
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2020
-
负责人:HELEN N JONES
-
依托单位:
International Federation of Placenta Associations
-
批准号:10220198
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2020
-
负责人:HELEN N JONES
-
依托单位:
International Federation of Placenta Associations
-
批准号:10543984
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2020
-
负责人:HELEN N JONES
-
依托单位:
Placental-specific therapy for fetal growth restriction
-
批准号:9518997
-
项目类别:
-
资助金额:$32.37万
-
财政年份:2017
-
负责人:HELEN N JONES
-
依托单位:
Placental-specific therapy for fetal growth restriction
-
批准号:10237421
-
项目类别:
-
资助金额:$31.01万
-
财政年份:2017
-
负责人:HELEN N JONES
-
依托单位:
Insulin-like Growth Factor 1 Gene Therapy; Correction of Placental Insufficiency
-
批准号:8820274
-
项目类别:
-
资助金额:$23.74万
-
财政年份:2014
-
负责人:HELEN N JONES
-
依托单位:
Insulin-like Growth Factor 1 Gene Therapy; Correction of Placental Insufficiency
-
批准号:9040002
-
项目类别:
-
资助金额:$23.54万
-
财政年份:2014
-
负责人:HELEN N JONES
-
依托单位:
Insulin-like Growth Factor 1 Gene Therapy; Correction of Placental Insufficiency
-
批准号:8786913
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2014
-
负责人:HELEN N JONES
-
依托单位:
Insulin-like Growth Factor 1 Gene Therapy; Correction of Placental Insufficiency
-
批准号:8301347
-
项目类别:
-
资助金额:$9.05万
-
财政年份:2012
-
负责人:HELEN N JONES
-
依托单位:
Insulin-like Growth Factor 1 Gene Therapy; Correction of Placental Insufficiency
-
批准号:8451409
-
项目类别:
-
资助金额:$9.17万
-
财政年份:2012
-
负责人:HELEN N JONES
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: